Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > ONCY's AWARE-1 study demonstrated positive signal in TNBC

View:

Post by Noteable on Jul 13, 2021 5:05pm

ONCY's AWARE-1 study demonstrated positive signal in TNBC

A seperate pre-clinical study by Vito el al. released yesterday (July 12, 2021) confirmed that a combination immunotherapy platform utilizing low dose chemotherapy (FEC) combined with oncolytic virotherapy (oHSV-1) increases tumor-infiltrating lymphocytes, in otherwise immune-bare tumors, allowing 60% of mice to achieve durable tumor regression when treated with immune checkpoint blockade.

272

Comment

Comment by unNoteable on Jul 13, 2021 5:48pm

It's well and good showing efficacy in mice, but I thought the general aim of the company was to treat mBC in humans. Murine trials once translated into humans will require 5-10 years before commercialisation. Without an approved product / partnership or outright buyout, ONCY won't last that long. I know this doesn't fit your rose-tinted view of Oncolytics Biotech, but considering ...more

216

Comment

Comment by JohnnyYeg on Jul 13, 2021 9:21pm

F**k right off unNoteable! What a pathetic sleaze bag you are having to piggy back on someone else's username to spread your pathetic brand slime. Grow up, and grow a pair you worm.

183

Comment

Comment by unNoteable on Jul 14, 2021 12:23pm